| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| RBPJ |
REC-1 (Mantle cell lymphoma) |
Treatment: GSI-washout |
Permissive
|
Homo sapiens |
GSE97541
...
|
MA1116.1
|
| RBPJ |
LAL-B (All-B patient-derived cell line) |
Treatment: chronic 1 uM dasatinib; |
Permissive
|
Homo sapiens |
GSE74557
...
|
MA1116.1
|
| RBPJ |
LAL-B (All-B patient-derived cell line) |
Treatment: 12 day 1 uM dasatinib; |
Permissive
|
Homo sapiens |
GSE74557
...
|
MA1116.1
|
| RBPJ |
LAL-B (All-B patient-derived cell line) |
Treatment: none; |
Permissive
Robust
|
Homo sapiens |
GSE74557
...
|
MA1116.1
|
| RBPJ |
C2C12 (myoblasts) |
Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 6 hrs; |
Permissive
|
Mus musculus |
GSE37184
...
|
MA1116.1
|
| RBPJ |
C2C12 (myoblasts) |
DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs |
Permissive
|
Mus musculus |
GSE37184
...
|
MA1116.1
|
| RBPJ |
C2C12 (myoblasts) |
Treatment: doxycycline; Genotype: NICDGFP; |
Permissive
Robust
|
Mus musculus |
GSE37184
...
|
MA1116.1
|
| RBPJ |
C2C12 (myoblasts) |
DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs |
Permissive
|
Mus musculus |
GSE37184
...
|
MA1116.1
|
| RBPJ |
C2C12 (myoblasts) |
Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 24 hrs; |
Permissive
|
Mus musculus |
GSE37184
...
|
MA1116.1
|
| RBPJ |
C2C12 (myoblasts) |
DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 24hrs |
Permissive
|
Mus musculus |
GSE37184
...
|
MA1116.1
|
Showing 10 records in page 2
from 5 pages